Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer [Yahoo! Finance]
iRhythm Technologies, Inc. (IRTC)
Last irhythm technologies, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.irhythmtech.com
Company Research
Source: Yahoo! Finance
CHICAGO, April 15, 2025 BUSINESS WIRE )--Turing Medical, a leader in precision brain mapping and targeting technologies, announced the appointment of Kevin King, former CEO of iRhythm Technologies, Affymetrix and Thomson Reuters Healthcare, as the company's new President and Chief Executive Officer (CEO). Turing Medical is developing advanced functional connectivity MRI processing techniques with the potential to generate highly detailed, personalized circuit maps that could help in the understanding and treatment of brain disorders. "Bringing Kevin King on as CEO marks a defining moment for Turing," said Nico Dosenbach, co-founder of Turing Medical. "As CEO of iRhythm, Kevin built one of the most successful digital health companies of our time—changing the standard of care for millions living with heart conditions. His track record of turning bold ideas into widely adopted clinical solutions makes him the ideal leader to help Turing redefine how we treat serious brain disorders."
Show less
Read more
Impact Snapshot
Event Time:
IRTC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRTC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRTC alerts
High impacting iRhythm Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
IRTC
News
- iRhythm Technologies (NASDAQ:IRTC) had its price target lowered by analysts at Truist Financial Corporation from $230.00 to $215.00. They now have a "buy" rating on the stock.MarketBeat
- HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law FirmGlobeNewswire
- iRhythm Technologies (NASDAQ:IRTC) had its price target raised by analysts at Morgan Stanley from $195.00 to $205.00. They now have an "overweight" rating on the stock.MarketBeat
- HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
IRTC
Earnings
- 10/30/25 - Beat
IRTC
Sec Filings
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- 12/2/25 - Form 4
- IRTC's page on the SEC website